- Home
- GNLN vs ADTX Comparison
GNLN vs ADTX Comparison
Compare GNLN & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- ADTX
- Stock Information
- Founded
- GNLN 2005
- ADTX 2017
- Country
- GNLN United States
- ADTX United States
- Employees
- GNLN N/A
- ADTX N/A
- Industry
- GNLN Durable Goods
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- GNLN Consumer Discretionary
- ADTX Health Care
- Exchange
- GNLN Nasdaq
- ADTX Nasdaq
- Market Cap
- GNLN 5.8M
- ADTX 5.3M
- IPO Year
- GNLN 2019
- ADTX 2020
- Fundamental
- Price
- GNLN $0.01
- ADTX $1.54
- Analyst Decision
- GNLN
- ADTX
- Analyst Count
- GNLN 0
- ADTX 0
- Target Price
- GNLN N/A
- ADTX N/A
- AVG Volume (30 Days)
- GNLN 290.1M
- ADTX 106.5K
- Earning Date
- GNLN 05-15-2025
- ADTX 05-15-2025
- Dividend Yield
- GNLN N/A
- ADTX N/A
- EPS Growth
- GNLN N/A
- ADTX N/A
- EPS
- GNLN N/A
- ADTX N/A
- Revenue
- GNLN $9,818,000.00
- ADTX $55,323.00
- Revenue This Year
- GNLN $1,541.21
- ADTX $15,768.94
- Revenue Next Year
- GNLN N/A
- ADTX N/A
- P/E Ratio
- GNLN N/A
- ADTX N/A
- Revenue Growth
- GNLN N/A
- ADTX N/A
- 52 Week Low
- GNLN $0.01
- ADTX $1.34
- 52 Week High
- GNLN $21.80
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- GNLN 20.26
- ADTX 35.55
- Support Level
- GNLN $0.01
- ADTX $1.42
- Resistance Level
- GNLN $0.01
- ADTX $1.63
- Average True Range (ATR)
- GNLN 0.00
- ADTX 0.13
- MACD
- GNLN 0.01
- ADTX 0.13
- Stochastic Oscillator
- GNLN 20.00
- ADTX 40.82
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.